本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

26.17
+0.53002.07%
盤後26.170.00000.00%19:30 EDT
成交量:70.55萬
成交額:1,856.59萬
市值:29.40億
市盈率:-15.37
高:26.75
開:26.04
低:25.91
收:25.64
52周最高:34.72
52周最低:15.96
股本:1.12億
流通股本:9,711.04萬
量比:0.51
換手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
淨資產收益率:-26.91%
總資產收益率:-14.75%
市淨率:4.84
市盈率(LYR):-16.33

資料載入中...

2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

SEC問詢函

Form CORRESP - Correspondence
2024/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence